Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goh Ohji

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Vaccines|November 11, 2022
A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation PatientsMarika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
International Journal of Hematology|January 4, 2022
Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibodyYohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Vaccines|November 11, 2022
A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation PatientsMarika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
International Journal of Hematology|January 4, 2022
Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibodyYohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, et al.
Pageof 6